Patients’ attention to and understanding of adverse drug reaction warnings

References

• Institute of Medicine. Preventing Medication Errors. In: Aspden P, Wolcott J, Bottman L, Cronenwett LR, editors. Washington, DC: National Academy Press; 2006.
   Google Scholar
• Wolf MS, Davis TC, Tilson HH, Bass PF, Parker RM. Misunderstanding of prescription drug warning labels among patients with low literacy. Am J Health-Syst Pharm. 2006;63:1048–1055.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Drug Monitoring: The role of the hospital. Geneva, Switzerland: World Health Organization; 1969. Technical Report Series Nr 425:5–24.
   Google Scholar
• Agency for Healthcare Research and Quality. US Department of Health and Human Services. Reducing and preventing adverse drug events to decrease hospital costs. Research in Action, Issue 1. Available at: http://www.ahrq.gov/qual/aderia/aderia.htm. Accessed 2010 Oct 10.
   Google Scholar
• Rodriguez-Monguior R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21;623–650.
   Web of Science ®Google Scholar
• Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–1205.
   PubMed Web of Science ®Google Scholar
• Sikdar KC, Alaghehbandan R, MacDonald D, et al. Adverse drug events in adult patients leading to emergency department visits. Ann Pharmacotherapy. 2010;44:641–649.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18, 820 patients. BMJ. 2004;329:15–19.
   PubMed Web of Science ®Google Scholar
• Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20:317–323.
   PubMed Web of Science ®Google Scholar
• Carrigan N, Raynor DK, Knapp P. Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UK. Drug Safety. 2008;31:305–312.
   PubMed Web of Science ®Google Scholar
• Fuchs J, Hippius M, Schaefer M. Analysis of German package inserts. Int J Clin Pharmacol Ther. 2006;44:8–13.
   PubMed Web of Science ®Google Scholar
• Wallace LS, Keenum AJ, Roskos SE, Blake GH, Colwell ST, Weiss BD. Suitability and readability of consumer medical information accompanying prescription medication samples. Patient Educ Couns. 2008;70:420–425.
   PubMed Web of Science ®Google Scholar
• Twomey C. An analysis of patient information leaflets supplied with medicines sold by pharmacists in the United Kingdom. Library Inf Res News. 2001;25:3–12.
   Google Scholar
• Bernardini C, Ambrogi V, Fardella G, Perioli L, Grandolini G. How to improve the readability of the patient package leaflet: a survey on the use of colour, print size, and layout. Pharmacol Res. 2001 ;43: 437–443.
   Google Scholar
• Lokker N, Sanders L, Perrin EM, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123:1464–1471.
   PubMed Web of Science ®Google Scholar
• Yin HS, Johnson M, Mendelsohn AL, Abrams MA, Sanders LM, Dreyer BP. The health literacy of parents in the United States: a nationally representative study. Pediatrics. 2009;124:S289-S298.
   PubMedGoogle Scholar
• Wolf MS, Davis TC, Bass PF, et al. Improving prescription drug warnings to promote patient comprehension. Arch Intern Med. 2010;170:50–56.
   PubMed Web of Science ®Google Scholar
• Davis TC, Wolf MS, Bass PF, et al. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006;21:847–851.
   PubMed Web of Science ®Google Scholar
• Peregrin T. Picture this: visual cues enhance health education messages for people with low literacy skills. J Am Diet Assoc. 2010;110:500–505.
   PubMedGoogle Scholar
• Shrank WH, Patrick A, Gleason PP, et al. An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes. Med Care. 2009;47:1031–1035.
   Web of Science ®Google Scholar
• Davis TC, Federman AD, Bass PF, et al. Improving patient understanding of prescription drug label instructions. J Gen Intern Med. 2008;24:57–62.
   Web of Science ®Google Scholar
• Morris LA. A survey of patients’ receipt of prescription drug information. Med Care. 1982;20:596–605.
   PubMed Web of Science ®Google Scholar
• Griffin JP, Griffin JR. Informing the patient. JR Coll Physicians Lond. 1996;30:107–111.
   Google Scholar
• Wilbur K, Salam SE, Mohammadi E. Patient perceptions of pharmacist roles in guiding self-medication of over-the-counter therapy in Qatar. Patient Prefer Adherence. 2010;4:87–93.
   Web of Science ®Google Scholar
• Nader F, Mousavizadeh K, Ghafourifar P. Patient sources for drug information in Iran: a questionnaire-based survey. Pharm World Sci. 2008;30:764–767.
   Google Scholar
• Hughes L, Whittlesea C, Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27:243–248.
   PubMed Web of Science ®Google Scholar
• Bernardini C, Ambrogi V, Perioli L, Tiralti MC, Fardella G. Comprehensibility of the package leaflets of all medicinal products for human use: a questionnaire survey about the use of symbols and pictograms. Pharmacol Res. 2000;41:679–688.
   Web of Science ®Google Scholar
• Vander Stichele RH, van Haecht CHV, Braem MD, Bogaert MG. Attitude of the public toward technical package inserts for medication information in Belgium. Ann Pharmacother. 1991;25:1002–1006.
   Web of Science ®Google Scholar
• Cullen G, Kelly E, Murry FE. Patients’ knowledge of adverse reactions to current medications. Br J Clin Pharmacol. 2006;62:232–236.
   PubMed Web of Science ®Google Scholar
• Koo MM, Krass I, Aslani P. Patient characteristics influencing evaluation of written medicine information: lessons for patient education. Ann Pharmacother. 2005;39:1434–1440.
   Web of Science ®Google Scholar
• Bosworth HB. Challenges and strategies to improve patient health literacy and competencies. Patient Intelligence. 2010;2:19–25.
   Google Scholar
• Nielsen-Bohlman LN, Panzer AM, Kindig DA, editors. Health Literacy: A prescription to end confusion. Washington, DC: National Academies Press; 2004.
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005: 353:487–497.
   PubMed Web of Science ®Google Scholar
• Powers B, Bosworth HB. Revisiting literacy and adherence: future clinical and research directions. J Gen Intern Med. 2006;21:823–828.
   Web of Science ®Google Scholar
• Wolf MS, Davis TC, Shrank W, et al. To err is human: patient misinterpretations of prescription drug label instructions. Patient Educ Couns. 2007;67:293–300.
   PubMed Web of Science ®Google Scholar
• Davis TC, Wolf MS, Bass PF, et al. Literacy and misunderstanding prescription drug labels. Ann Int Med. 2006;145:887–894.
   PubMed Web of Science ®Google Scholar
• Bailey SC, Pandit AU, Curtis L, Wolf MS. Availability of Spanish prescription labels: a multi-state pharmacy survey. Med Care. 2009;47:707–710.
   PubMedGoogle Scholar
• Stewart KA, Natske BM, Williams T, Granger E, Ward Casscells S, Croghan TW. Temporal trends in anti-diabetes drug use in tricare following safety warnings in 2007 about rosiglitazone. Pharmacoepidemiol Drug Saf. 2009;18:1048–1052.
   Web of Science ®Google Scholar
• Canadian Medical Association Journal. Anti-psychotic drug use in the elderly increases despite drug safety warnings. Media Release: 25 Aug 2008. Available from: http://www.eurekalert.org. Accessed 2010 Oct 11.
   Google Scholar
• Goldman SA. Communication of medical product risk: how effective is effective enough? Drug Saf. 2004;27:519–534.
   Web of Science ®Google Scholar
• May FW, Rowett DS, Gilbert AL, McNeece JI, Hurley E. Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. Med J Aust. 1999;170:471–474.
   PubMed Web of Science ®Google Scholar
• European Commission. EEC Directive 92/27/EEC on labeling of medicinal products for human use and on package leaflets (OJ Nr L113 of1992 Apr 30). Brussels, Belgium: EC Pharmaceuticals Committee; 1992.
   Google Scholar
• European Commission. A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use. Brussels, Belgium: EC Pharmaceuticals Committee;1998.
   Google Scholar
• European Commission. A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use. Brussels, Belgium: EC Pharmaceuticals Committee, 2009.
   Google Scholar
• Keystone Center. The Final Report of the Keystone National Policy Dialogue on Food, Nutrition, and Health. Washington DC: Keystone Center; 1996.
   Google Scholar
• Webb J, Davis TC, Bernadella P, et al. Patient-centered approach for improving prescription drug warning labels. Patient Educ Couns. 2008;72:443–449.
   PubMed Web of Science ®Google Scholar
• Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Educ Couns. 2007;67:157–168.
   Web of Science ®Google Scholar
• Roumie CL, Griffin MR. Over-the counter analgesics in older adults: a call for improved labelling and consumer education. Drugs Aging. 2004;21:485–498.
   PubMed Web of Science ®Google Scholar
• Healthy People 2010. Available from: http://www.healthypeople.gov/Document/tableofcontents.htm. Accessed 2010 Oct 11.
   Google Scholar
• Ziegler DK, Mosier MC, Buenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med. 2001;161:706–713.
   PubMed Web of Science ®Google Scholar
• de Maar EW, Kshirsagar NA, Darmansjah I. An Asian perspective on drug and related health care information. Drug Inf J. 1983;17:263–269.
   PubMedGoogle Scholar
• Kafle KK, Bhuju GB, Karkee SB, et al. An intervention improving prescribing practices and monitoring drugs availability in a district. Nepal Med Coll J. 2009;11:217–221.
   Google Scholar
• Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use os medicines in developing countries. Health Policy Plan. 2001;16:13–20.
   PubMed Web of Science ®Google Scholar
• Ross-Degnan D, Soumerai S, Goel PK, et al. The impact of face to face educational outreach on diarrhea treatment in pharmacies. Health Policy Plan. 1996;11:308–318.
   PubMed Web of Science ®Google Scholar